• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期诊断的2型糖尿病患者中伴或不伴黄斑水肿的糖尿病视网膜病变相关危险因素

Risk Factors Associated with Diabetic Retinopathy with and without Macular Edema in Recently Diagnosed Patients with Type 2 Diabetes.

作者信息

García-Ulloa Ana Cristina, Pérez-Peralta Liliana, Jaime-Casas Salvador, Jiménez-Corona Aida, Rivera-De La Parra David, Graue-Hernández Enrique Octavio, Hernández-Jiménez Sergio

机构信息

Centro de Atención Integral del Paciente con Diabetes (CAIPaDi) Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Instituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City, Mexico.

出版信息

Diabetes Metab Syndr Obes. 2024 Jan 16;17:231-238. doi: 10.2147/DMSO.S447658. eCollection 2024.

DOI:10.2147/DMSO.S447658
PMID:38249155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10799638/
Abstract

PURPOSE

To evaluate the risk factors associated with diabetic macular edema (DME) in patients with a recent type 2 diabetes mellitus (T2DM) diagnosis.

PATIENTS AND METHODS

We conducted a case-control study at a third-level hospital in Mexico City. We enrolled patients ≥18 years old, with T2DM less than five years of diagnosis, without disabling complications, and non-smokers. The control group was patients with diabetic retinopathy and without macular edema (DR-DME). Cases were patients with DR+DME. We measured fasting glucose, creatinine, lipid profile, urinary albumin/creatinine ratio (ACR), and HbA1c. An ophthalmological examination consisted of visual acuity measurement, digital three-field fundus photography with an automatic non-mydriatic camera, slit lamp, and Optical coherence tomography (OCT) examination.

RESULTS

183 and 61 patients with DR-DME and DR+DME, respectively, were included in the analysis. The prevalence of mild DR was higher in the DR-DME group, but the frequencies of moderate and severe retinopathy were higher in the DR+DME group. Patients in the DR-DME group had better vision than those in the DR+DME group. Logistic regression analysis revealed that age (OR, 1.07), HbA1c (OR, 1.19), and Albumin-to-Creatinine Ratio (ACR) > 30 mg/g (OR, 3.37) were associated with an increased possibility of DME compared to DR-DME.

CONCLUSION

Our study provides insights into the association between risk factors and DME. We found a statistically strong association between HbA1c levels, age, and ACR. Patients with poor metabolic control should undergo an extensive medical examination to screen for DME, which may be related to the chronicity of DM and renal damage.

摘要

目的

评估近期诊断为2型糖尿病(T2DM)的患者发生糖尿病性黄斑水肿(DME)的相关危险因素。

患者与方法

我们在墨西哥城的一家三级医院开展了一项病例对照研究。纳入年龄≥18岁、确诊T2DM少于5年、无致残并发症且不吸烟的患者。对照组为患有糖尿病视网膜病变但无黄斑水肿(DR-DME)的患者。病例组为患有DR+DME的患者。我们测量了空腹血糖、肌酐、血脂谱、尿白蛋白/肌酐比值(ACR)和糖化血红蛋白(HbA1c)。眼科检查包括视力测量、使用自动免散瞳相机进行的数字三维眼底摄影、裂隙灯检查和光学相干断层扫描(OCT)检查。

结果

分别有183例和61例DR-DME和DR+DME患者纳入分析。DR-DME组轻度DR的患病率较高,但DR+DME组中度和重度视网膜病变的发生率较高。DR-DME组患者的视力优于DR+DME组患者。逻辑回归分析显示,与DR-DME相比,年龄(比值比[OR],1.07)、HbA1c(OR,1.19)和白蛋白与肌酐比值(ACR)>30 mg/g(OR,3.37)与发生DME的可能性增加相关。

结论

我们的研究为危险因素与DME之间的关联提供了见解。我们发现HbA1c水平、年龄和ACR之间存在统计学上的强关联。代谢控制不佳的患者应接受全面的医学检查以筛查DME,这可能与糖尿病的慢性病程和肾脏损害有关。

相似文献

1
Risk Factors Associated with Diabetic Retinopathy with and without Macular Edema in Recently Diagnosed Patients with Type 2 Diabetes.近期诊断的2型糖尿病患者中伴或不伴黄斑水肿的糖尿病视网膜病变相关危险因素
Diabetes Metab Syndr Obes. 2024 Jan 16;17:231-238. doi: 10.2147/DMSO.S447658. eCollection 2024.
2
Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.在亚洲 2 型糖尿病人群中,异常肾脏图谱与增生性糖尿病视网膜病变和糖尿病性黄斑水肿的相关性。
JAMA Ophthalmol. 2018 Jan 1;136(1):68-74. doi: 10.1001/jamaophthalmol.2017.5202.
3
[Association of choroidal thickness with diabetic retinopathy at different stages].[不同阶段糖尿病视网膜病变与脉络膜厚度的相关性]
Zhonghua Yi Xue Za Zhi. 2015 Aug 25;95(32):2584-8.
4
Differential association of serum lipids with diabetic retinopathy and diabetic macular edema.血清脂质与糖尿病视网膜病变和糖尿病黄斑水肿的关联差异。
Invest Ophthalmol Vis Sci. 2011 Sep 27;52(10):7464-9. doi: 10.1167/iovs.11-7598.
5
Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy.光学相干断层扫描用于检测糖尿病视网膜病变患者的早期黄斑水肿。
Folia Med (Plovdiv). 2010 Jan-Mar;52(1):40-8.
6
Retinal microvascular changes in diabetic patients with diabetic nephropathy.糖尿病肾病患者的视网膜微血管变化。
BMC Endocr Disord. 2023 May 5;23(1):101. doi: 10.1186/s12902-022-01250-w.
7
Choriocapillaris Flow Deficit as a Biomarker for Diabetic Retinopathy and Diabetic Macular Edema: 3-Year Longitudinal Cohort.脉络膜血流不足作为糖尿病视网膜病变和糖尿病黄斑水肿的生物标志物:一项 3 年纵向队列研究。
Am J Ophthalmol. 2023 Apr;248:76-86. doi: 10.1016/j.ajo.2022.11.018. Epub 2022 Nov 24.
8
Comparison of Handheld Retinal Imaging with ETDRS 7-Standard Field Photography for Diabetic Retinopathy and Diabetic Macular Edema.手持式视网膜成像与 ETDRS 7 标准视野摄影在糖尿病视网膜病变和糖尿病黄斑水肿中的比较。
Ophthalmol Retina. 2022 Jul;6(7):548-556. doi: 10.1016/j.oret.2022.03.002. Epub 2022 Mar 9.
9
[Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].评估激光治疗糖尿病性黄斑病变的有效性。
Pol Merkur Lekarski. 2013 Jun;34(204):351-4.
10
Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus.早发和晚发糖尿病患者糖尿病视网膜病变和糖尿病黄斑水肿的患病率及其危险因素。
Ophthalmic Res. 2022;65(3):293-299. doi: 10.1159/000508335. Epub 2020 Apr 30.

引用本文的文献

1
One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population.拉丁裔人群玻璃体内注射新型抗血管内皮生长因子治疗糖尿病性黄斑水肿后一年的视觉反应结果
Int J Retina Vitreous. 2025 Aug 1;11(1):89. doi: 10.1186/s40942-025-00719-9.

本文引用的文献

1
Ocular Complications of Diabetes and Therapeutic Approaches.糖尿病的眼部并发症及治疗方法
J Clin Med. 2022 Sep 1;11(17):5170. doi: 10.3390/jcm11175170.
2
Impact of risk factors related to metabolic syndrome on acute myocardial infarction in younger patients.代谢综合征相关危险因素对年轻患者急性心肌梗死的影响。
Hypertens Res. 2022 Sep;45(9):1447-1458. doi: 10.1038/s41440-022-00951-y. Epub 2022 Jun 9.
3
Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project.糖尿病性黄斑水肿不良视觉结局的特征:抗击视网膜病变!计划。
Ophthalmol Retina. 2022 Jul;6(7):540-547. doi: 10.1016/j.oret.2022.03.007. Epub 2022 Mar 17.
4
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.脂质、高反射性结晶沉积物和糖尿病视网膜病变:降脂治疗的潜在全身和视网膜特异性作用。
Diabetologia. 2022 Apr;65(4):587-603. doi: 10.1007/s00125-022-05655-z. Epub 2022 Feb 11.
5
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.2. 糖尿病的分类和诊断:2022 年糖尿病医疗护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002.
6
Optical Coherence Tomography Classification Systems for Diabetic Macular Edema and Their Associations With Visual Outcome and Treatment Responses - An Updated Review.光学相干断层扫描分类系统在糖尿病性黄斑水肿及其与视觉结局和治疗反应的相关性中的应用——最新综述。
Asia Pac J Ophthalmol (Phila). 2022 Jun 1;11(3):247-257. doi: 10.1097/APO.0000000000000468.
7
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
8
Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.代谢健康表型的自然病程及发生心血管代谢疾病的风险:一项为期三年的随访研究。
BMC Endocr Disord. 2021 Apr 28;21(1):85. doi: 10.1186/s12902-021-00754-1.
9
NATURAL HISTORY AND PREDICTORS OF VISION LOSS IN EYES WITH DIABETIC MACULAR EDEMA AND GOOD INITIAL VISUAL ACUITY.糖尿病性黄斑水肿伴良好初始视力眼的自然病程和视力丧失的预测因素。
Retina. 2021 Oct 1;41(10):2132-2139. doi: 10.1097/IAE.0000000000003167.
10
Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis.钠-葡萄糖协同转运蛋白 2 抑制剂通过减少自噬对心肌梗死的心脏保护作用机制。
Protein Cell. 2022 May;13(5):336-359. doi: 10.1007/s13238-020-00809-4. Epub 2021 Jan 8.